Rituximab desensitization protocol in a child with secondary lymphoproliferative disease
Ann Allergy Asthma Immunol
.
2019 Nov;123(5):526.
doi: 10.1016/j.anai.2019.09.004.
Authors
Carolina S Aranda
1
,
Luis Felipe Ensina
2
,
Marcia C Mallozi
2
,
Vicente Odone Filho
3
,
Dirceu Solé
2
Affiliations
1
Federal University, São Paulo, Brazil. Electronic address: carolaaranda@yahoo.com.br.
2
Federal University, São Paulo, Brazil.
3
University of São Paulo, São Paulo, Brazil.
PMID:
31676020
DOI:
10.1016/j.anai.2019.09.004
No abstract available
Publication types
Letter
Comment
MeSH terms
Child
Connective Tissue Diseases*
Desensitization, Immunologic
Humans
Lymphoproliferative Disorders*
Neoplasms*
Rituximab
Substances
Rituximab